$LVO
LiveOne, Inc.

2024 Q1 Form 10-Q Financial Statement

#000143774924003800 Filed on February 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $30.90M $31.25M
YoY Change 20.94% 14.41%
Cost Of Revenue $23.38M $23.27M
YoY Change 27.77% 20.17%
Gross Profit $7.523M $7.978M
YoY Change 3.72% 0.39%
Gross Profit Margin 24.35% 25.53%
Selling, General & Admin $6.794M $7.394M
YoY Change 7.79% 20.36%
% of Gross Profit 90.31% 92.68%
Research & Development $1.302M $694.0K
YoY Change 75.47% -32.95%
% of Gross Profit 17.31% 8.7%
Depreciation & Amortization $588.0K $800.0K
YoY Change -37.71% -27.27%
% of Gross Profit 7.82% 10.03%
Operating Expenses $8.684M $8.088M
YoY Change 7.04% 12.68%
Operating Profit -$1.161M -$753.0K
YoY Change 35.0% 31.18%
Interest Expense -$889.0K -$1.279M
YoY Change -42.57% -42.39%
% of Operating Profit
Other Income/Expense, Net -$520.0K -$1.486M
YoY Change -72.89% -24.3%
Pretax Income -$2.570M -$2.239M
YoY Change -52.05% 20254.55%
Income Tax $75.00K -$15.00K
% Of Pretax Income
Net Earnings -$1.954M -$1.574M
YoY Change -63.88% -38.23%
Net Earnings / Revenue -6.32% -5.04%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.02 -$0.02
COMMON SHARES
Basic Shares Outstanding 91.66M 91.18M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.987M $6.248M
YoY Change -16.91% -24.29%
Cash & Equivalents $6.987M $6.248M
Short-Term Investments
Other Short-Term Assets $2.342M $1.762M
YoY Change -23.54% -41.13%
Inventory $1.801M $2.092M
Prepaid Expenses
Receivables $13.21M $16.06M
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.34M $26.16M
YoY Change -12.23% -5.66%
LONG-TERM ASSETS
Property, Plant & Equipment $3.646M $3.634M
YoY Change -2.72% -1.17%
Goodwill $23.38M $23.38M
YoY Change 0.0% 0.0%
Intangibles $12.42M $12.54M
YoY Change 12.51% 11.14%
Long-Term Investments
YoY Change
Other Assets $0.00 $122.0K
YoY Change -100.0% -75.94%
Total Long-Term Assets $39.44M $39.67M
YoY Change 3.35% 2.13%
TOTAL ASSETS
Total Short-Term Assets $24.34M $26.16M
Total Long-Term Assets $39.44M $39.67M
Total Assets $63.78M $65.83M
YoY Change -3.21% -1.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.59M $10.31M
YoY Change 142.63% -43.61%
Accrued Expenses $10.86M $13.26M
YoY Change -55.91% 144.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $7.692M $7.694M
YoY Change 51180.0% 51193.33%
Total Short-Term Liabilities $46.48M $47.68M
YoY Change 4.5% 0.55%
LONG-TERM LIABILITIES
Long-Term Debt $771.0K $941.0K
YoY Change -89.21% -96.44%
Other Long-Term Liabilities $9.354M $7.406M
YoY Change -7.52% 58.45%
Total Long-Term Liabilities $10.13M $7.406M
YoY Change -41.35% -76.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.48M $47.68M
Total Long-Term Liabilities $10.13M $7.406M
Total Liabilities $67.28M $56.64M
YoY Change 8.39% -28.19%
SHAREHOLDERS EQUITY
Retained Earnings -$239.0M -$236.0M
YoY Change 6.56% 8.01%
Common Stock $92.00K $91.00K
YoY Change 2.22% 3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.782M $3.863M
YoY Change 121.18% 99.33%
Treasury Stock Shares
Shareholders Equity -$3.509M -$4.689M
YoY Change
Total Liabilities & Shareholders Equity $63.78M $65.83M
YoY Change -3.21% -1.11%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.954M -$1.574M
YoY Change -63.88% -38.23%
Depreciation, Depletion And Amortization $588.0K $800.0K
YoY Change -37.71% -27.27%
Cash From Operating Activities $3.044M $3.849M
YoY Change 289.76% 77.13%
INVESTING ACTIVITIES
Capital Expenditures $1.266M $980.0K
YoY Change 215.71% 27.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.266M -$980.0K
YoY Change 215.71% 27.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.089M -227.0K
YoY Change 386.16% -24.33%
NET CHANGE
Cash From Operating Activities 3.044M 3.849M
Cash From Investing Activities -1.266M -980.0K
Cash From Financing Activities -1.089M -227.0K
Net Change In Cash 689.0K 2.642M
YoY Change 341.67% 139.75%
FREE CASH FLOW
Cash From Operating Activities $3.044M $3.849M
Capital Expenditures $1.266M $980.0K
Free Cash Flow $1.778M $2.869M
YoY Change 367.89% 104.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000
CY2023Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
5000
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5000
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
5000
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
18604
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
18604
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16177
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16177
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91625688
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91625688
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89632161
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89632161
lvo Stock Issued During The Period Shares Settlement Of Earnout
StockIssuedDuringThePeriodSharesSettlementOfEarnout
414137
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1000000
lvo Stock Issued During Period Shares Settlement Of Liabilities
StockIssuedDuringPeriodSharesSettlementOfLiabilities
1397918
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
100000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2022Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
100000 usd
CY2020Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2000000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38249
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0657263
dei Entity Address Address Line1
EntityAddressAddressLine1
269 S. Beverly Dr., Suite #1450
dei Entity Address City Or Town
EntityAddressCityOrTown
Beverly Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90212
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
601-2505
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
LVO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91655688
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6248000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8409000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
205000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
240000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16057000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13658000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2092000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2596000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1557000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2823000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
26159000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
27726000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3634000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3325000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
23379000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
23379000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12536000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11035000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
122000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
423000 usd
CY2023Q4 us-gaap Assets
Assets
65830000 usd
CY2023Q1 us-gaap Assets
Assets
65888000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23748000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22772000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
15453000 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
12826000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
694000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
15000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
788000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
992000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7000000 usd
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Bridge Loan
BridgeLoan
0 usd
CY2023Q1 us-gaap Bridge Loan
BridgeLoan
4726000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3148000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47683000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44479000 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2023Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
7000000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
941000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
148000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
161000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
279000 usd
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
376000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7406000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9578000 usd
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
332000 usd
CY2023Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
332000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
56641000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
62074000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
4933000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
4827000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
18604000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
16177000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
91000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
90000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
216433000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209151000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3863000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2162000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-235954000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-224269000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4689000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1013000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
8945000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
0 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4256000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1013000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65830000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65888000 usd
CY2023Q4 us-gaap Revenues
Revenues
31245000 usd
CY2022Q4 us-gaap Revenues
Revenues
27309000 usd
us-gaap Revenues
Revenues
87541000 usd
us-gaap Revenues
Revenues
74063000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
23267000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
19362000 usd
us-gaap Cost Of Revenue
CostOfRevenue
63015000 usd
us-gaap Cost Of Revenue
CostOfRevenue
48487000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1514000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1608000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5671000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6334000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
694000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1035000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3379000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3892000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5880000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4535000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17641000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11220000 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
115000 usd
CY2022Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
115000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1356000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
528000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1343000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1227000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4098000 usd
CY2023Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
31998000 usd
CY2022Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
27883000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
91048000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
75387000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-753000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-574000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3507000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1324000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1279000 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2220000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3477000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5793000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-207000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
257000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3639000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2523000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1486000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1963000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7116000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3270000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2239000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2537000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10623000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4594000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-2224000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-2548000 usd
us-gaap Profit Loss
ProfitLoss
-10666000 usd
us-gaap Profit Loss
ProfitLoss
-4609000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-650000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-997000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1574000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2548000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9669000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4609000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87882364
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85585117
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87477623
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84009003
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1013000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
484000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
626000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
393000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1013000 usd
CY2023Q2 lvo Net Income Loss Including Noncontrolling Interest
NetIncomeLossIncludingNoncontrollingInterest
-515000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2290000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1767000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
917000 usd
CY2023Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
628000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4752000 usd
CY2023Q3 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
0 usd
CY2023Q3 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
CY2023Q3 lvo Reclassifications Of Common Stock Warrants
ReclassificationsOfCommonStockWarrants
5896000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
521000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2023Q3 lvo Stock Issued During Period Value Preferred Shares
StockIssuedDuringPeriodValuePreferredShares
1053000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
575000 usd
CY2023Q3 lvo Net Income Loss Including Noncontrolling Interest
NetIncomeLossIncludingNoncontrollingInterest
-7927000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3494000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2318000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q4 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
762000 usd
CY2023Q4 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
169000 usd
CY2023Q4 lvo Stock Issued During Period Value Preferred Shares
StockIssuedDuringPeriodValuePreferredShares
1374000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
113000 usd
CY2023Q4 lvo Net Income Loss Including Noncontrolling Interest
NetIncomeLossIncludingNoncontrollingInterest
-2224000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4256000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10916000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
788000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
997000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1348000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9777000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1396000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
2000 usd
CY2022Q3 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1142000 usd
CY2022Q3 lvo Stock Issued During Period Value Settlement Of Earnout
StockIssuedDuringPeriodValueSettlementOfEarnout
493000 usd
CY2022Q3 lvo Stock Issued During Period Value Settlement Of Accrued Expenses
StockIssuedDuringPeriodValueSettlementOfAccruedExpenses
945000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
941000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3409000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10149000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
386000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2548000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-12311000 usd
us-gaap Profit Loss
ProfitLoss
-10666000 usd
us-gaap Profit Loss
ProfitLoss
-4609000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3668000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7025000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
269000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
320000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5419000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2544000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1110000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2652000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-4132000 usd
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
732000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
174000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2220000 usd
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
106000 usd
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7649000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
509000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
146000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
115000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1356000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2908000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
198000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1312000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1544000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-504000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-255000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-221000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-204000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-168000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-3599000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-3057000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3606000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1284000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3804000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4627000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2092000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2036000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
688000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
13000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2780000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2049000 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
3000000 usd
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
-0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-227000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-426000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1700000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 usd
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
4376000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1701000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1938000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3220000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2012000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2196000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4664000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8649000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13154000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6453000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8490000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
37000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
869000 usd
us-gaap Interest Paid Net
InterestPaidNet
1294000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4752000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1574000 usd
lvo Accrual Of Dividends
AccrualOfDividends
2016000 usd
lvo Accrual Of Dividends
AccrualOfDividends
0 usd
CY2023Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
0 usd
CY2022Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
3107000 usd
lvo Stock Issued During Period Value Settlement Of Earnout
StockIssuedDuringPeriodValueSettlementOfEarnout
0 usd
lvo Stock Issued During Period Value Settlement Of Earnout
StockIssuedDuringPeriodValueSettlementOfEarnout
493000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1142000 usd
lvo Stock Issued During Period Value Settlement Of Accrued Expenses
StockIssuedDuringPeriodValueSettlementOfAccruedExpenses
0 usd
lvo Stock Issued During Period Value Settlement Of Accrued Expenses
StockIssuedDuringPeriodValueSettlementOfAccruedExpenses
945000 usd
lvo Common Stock Issued For Prepaid Services
CommonStockIssuedForPrepaidServices
422000 usd
lvo Common Stock Issued For Prepaid Services
CommonStockIssuedForPrepaidServices
0 usd
CY2023Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
5896000 usd
CY2022Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
0 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
737000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
lvo Fair Value Of Intangible Assets Acquired With Common Shares
FairValueOfIntangibleAssetsAcquiredWithCommonShares
917000 usd
lvo Fair Value Of Intangible Assets Acquired With Common Shares
FairValueOfIntangibleAssetsAcquiredWithCommonShares
0 usd
lvo Fair Value Of Options To Employees Capitalized As Software
FairValueOfOptionsToEmployeesCapitalizedAsSoftware
655000 usd
lvo Fair Value Of Options To Employees Capitalized As Software
FairValueOfOptionsToEmployeesCapitalizedAsSoftware
26000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6500000 usd
us-gaap Profit Loss
ProfitLoss
-10700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3800000 usd
CY2023Q4 lvo Working Capital
WorkingCapital
21500000 usd
CY2023Q4 lvo Potential Financing Amount
PotentialFinancingAmount
150000000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of the Company’s condensed consolidated financial statements in conformity with the United States of America (“US”) generally accepted accounting principles (“GAAP”) requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, inventory calculations and reserves, the fair value of the Company’s equity-based compensation awards and convertible debt and debenture instruments, fair values of derivatives, and contingencies. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. Given the overall uncertainty surrounding the COVID-<em style="font: inherit;">19</em> pandemic, there is a reasonable possibility that actual results could differ from those estimates and such differences could be material to the financial position and results of operations, specifically in assessing when the collectability of revenue related consideration is probable, and the impairment assessment of goodwill, indefinite lived assets or long-lived assets that are depreciated or amortized.</p>
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
100000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2266667
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2431681
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5960593
us-gaap Net Income Loss
NetIncomeLoss
-9669000 usd
CY2023Q4 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
762000 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2016000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2336000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11685000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87882364
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87477623
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6248000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8409000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
205000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
240000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6453000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8649000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
17136000 usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
14228000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1079000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
570000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
16057000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
13658000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the <em style="font: inherit;">$250,000</em> amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p>
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31245000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27309000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87541000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
74063000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
992000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
392000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
188000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
788000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24993000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22250000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21360000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18925000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3634000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3325000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
800000 usd
us-gaap Depreciation
Depreciation
1100000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
2400000 usd
us-gaap Depreciation
Depreciation
2900000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
23379000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
23379000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39098000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-31199000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7899000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
36422000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-30024000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6398000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4100000 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
100000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1400000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
533000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2041000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1732000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1023000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
508000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2062000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7899000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10307000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
10960000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13260000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11539000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
273000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
23748000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
22772000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1635000 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
163000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
694000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
15000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
941000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
148000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
181000 usd
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.085 pure
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
us-gaap Operating Lease Cost
OperatingLeaseCost
615000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
373000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
88000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
46000 usd
us-gaap Lease Cost
LeaseCost
703000 usd
us-gaap Lease Cost
LeaseCost
419000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
175000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
423000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
273000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
161000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
181000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
434000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
65000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
140000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
205000 usd
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
0 usd
CY2023Q1 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
174000 usd
CY2023Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
4767000 usd
CY2023Q1 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
3788000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
2619000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
5616000 usd
CY2023Q4 lvo Other Liabilities Noncurrent Miscellaneous
OtherLiabilitiesNoncurrentMiscellaneous
20000 usd
CY2023Q1 lvo Other Liabilities Noncurrent Miscellaneous
OtherLiabilitiesNoncurrentMiscellaneous
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7406000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9578000 usd
CY2023Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
100000 usd
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.05 pure
CY2023Q4 lvo Stock Authorized
StockAuthorized
510000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 lvo Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
2000000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1101498
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2000000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1700000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1900000 usd
CY2023Q3 lvo Stock Issued To Noncontrolling Owners
StockIssuedToNoncontrollingOwners
4300000
CY2023Q3 lvo Stock Issued To Noncontrolling Owners
StockIssuedToNoncontrollingOwners
4300000
CY2023Q3 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
1500000 usd
lvo Stock Issued To Noncontrolling Owners
StockIssuedToNoncontrollingOwners
3200000
us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
2500000 usd
CY2023Q4 us-gaap Revenues
Revenues
31245000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-2224000 usd
CY2022Q4 us-gaap Revenues
Revenues
27309000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-2548000 usd
us-gaap Revenues
Revenues
87541000 usd
us-gaap Profit Loss
ProfitLoss
-10666000 usd
us-gaap Revenues
Revenues
74063000 usd
us-gaap Profit Loss
ProfitLoss
-4609000 usd

Files In Submission

Name View Source Status
0001437749-24-003800-index-headers.html Edgar Link pending
0001437749-24-003800-index.html Edgar Link pending
0001437749-24-003800.txt Edgar Link pending
0001437749-24-003800-xbrl.zip Edgar Link pending
ex_613067.htm Edgar Link pending
ex_613068.htm Edgar Link pending
ex_613069.htm Edgar Link pending
ex_613070.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lvo-20231231.xsd Edgar Link pending
lvo20231231_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
lvo-20231231_cal.xml Edgar Link unprocessable
lvo-20231231_def.xml Edgar Link unprocessable
lvo-20231231_lab.xml Edgar Link unprocessable
lvo-20231231_pre.xml Edgar Link unprocessable
lvo20231231_10q_htm.xml Edgar Link completed
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable